Evidence map›Paper›PMID 35290738›Full record

ArticleNano letters2022

Simultaneous Multicolor DNA-PAINT without Sequential Fluid Exchange Using Spectral Demixing.

Niclas Gimber, Sebastian Strauss, Ralf Jungmann, Jan Schmoranzer

Abstract read
In one paragraph

Article in Nano letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Niclas GimberAdvanced Medical Bioimaging Core Facility, Charité-Universitätsmedizin, 10117 Berlin, Germany.ORCID 0000-0001-9456-3063
Sebastian StraussFaculty of Physics and Center for Nanoscience, Ludwig Maximilian University, 80799 Munich, Germany.ORCID 0000-0002-4653-1451
Ralf JungmannFaculty of Physics and Center for Nanoscience, Ludwig Maximilian University, 80799 Munich, Germany.ORCID 0000-0003-4607-3312
Jan SchmoranzerAdvanced Medical Bioimaging Core Facility, Charité-Universitätsmedizin, 10117 Berlin, Germany.ORCID 0000-0002-4482-7080

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several variants of multicolor single-molecule localization microscopy (SMLM) have been developed to resolve the spatial relationship of nanoscale structures in biological samples. The oligonucleotide-based SMLM approach "DNA-PAINT" robustly achieves nanometer localization precision and can be used to count binding sites within nanostructures. However, multicolor DNA-PAINT has primarily been realized by "Exchange-PAINT", which requires sequential exchange of the imaging solution and thus leads to extended acquisition times. To alleviate the need for fluid exchange and to speed up the acquisition of current multichannel DNA-PAINT, we here present a novel approach that combines DNA-PAINT with simultaneous multicolor acquisition using spectral demixing (SD). By using newly designed probes and a novel multichannel registration procedure, we achieve simultaneous multicolor SD-DNA-PAINT with minimal crosstalk. We demonstrate high localization precision (3-6 nm) and multicolor registration of dual- and triple-color SD-DNA-PAINT by resolving patterns on DNA origami nanostructures and cellular structures.

Indexed as

NanostructuresSingle Molecule ImagingDNAMicroscopy, FluorescenceOligonucleotidesDNAOligonucleotidesDNA-PAINTfluorescence microscopymulticolorsingle-molecule imagingsingle-molecule localization microscopyspectral demixingSuper-resolution

Identifiers

PMID35290738
PMCPMC9011399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.